Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
2017 · The Lancet · 1,204 citations
https://doi.org/10.1016/s0140-6736(17)30182-4
S
Sudarshan Paramsothy
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
150
Papers
4.9K
Citations
29
h-index
49
i10-index
Sudarshan Paramsothy is an academic researcher from The University of Sydney. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Gut microbiota and health. The author has an h-index of 29, co-authored 128 publications.
ORCID: 0000-0002-9097-6028Papers by this author
worksFecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions
2013 · Current Gastroenterology Reports · 282 citations
https://doi.org/10.1007/s11894-013-0337-1
International consensus statement on microbiome testing in clinical practice
2024 · The Lancet. Gastroenterology & hepatology · 62 citations
https://doi.org/10.1016/s2468-1253(24)00311-x
Profiling the colonic mucosal response to fecal microbiota transplantation identifies a role for GBP5 in colitis in humans and mice
2024 · Nature Communications · 14 citations
https://doi.org/10.1038/s41467-024-46983-5
Vedolizumab serum trough concentrations with and without thiopurines in ulcerative colitis: The prospective VIEWS pharmacokinetics study
2024 · World Journal of Gastroenterology · 2 citations
https://doi.org/10.3748/wjg.v31.i2.101292
Bacterial taxonomic and functional changes following oral lyophilized donor fecal microbiota transplantation in patients with ulcerative colitis
2025 · mSystems · 2 citations
https://doi.org/10.1128/msystems.00991-25
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat